Welcome to our dedicated page for Bankwell Financi SEC filings (Ticker: BWFG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Bankwell Financial Group, Inc. (NASDAQ: BWFG), the bank holding company for Bankwell Bank. Through these documents, investors can review how the company reports its commercial banking activities, financial condition, and capital position.
Bankwell’s periodic and current reports describe results of operations and financial condition, including net interest income, noninterest income, pre-tax, pre-provision net revenue (PPNR), net interest margin, and key profitability ratios such as return on average assets and return on average shareholders’ equity. Filings also present details on noninterest expense, efficiency ratio calculations, and explanations of non-GAAP financial measures.
The company discloses asset quality and credit metrics, including nonaccrual loans by portfolio segment, other real estate owned, nonperforming loans and nonperforming assets as a percentage of total loans and total assets, and the allowance for credit losses on loans. Tables in the filings show charge-offs, recoveries, and provision for credit losses over time, along with the relationship between the allowance and nonperforming loans.
Capital information is another focus of Bankwell’s regulatory reporting. Filings include total capital to risk-weighted assets, common equity tier 1 capital to risk-weighted assets, tier 1 capital to average assets, and tangible common equity to tangible assets. Dividend activity is also documented, with current reports on Form 8-K describing quarterly dividend declarations and related dates.
On Stock Titan, these SEC filings are updated from EDGAR and paired with AI-powered summaries that highlight important items, explain technical terms, and help readers interpret complex tables and ratios. Users can quickly identify key trends in earnings, credit quality, capital, and dividends without reading every line of the underlying documents, while still having direct access to the full filings for deeper analysis.
Bankwell Financial Group EVP & Chief Credit Officer Christine Chivily reported multiple stock transactions on February 9, 2026. She received 2,054 shares under the 2022 stock plan, split between time-based restricted stock vesting from February 7, 2027 and performance shares that may cliff vest on February 7, 2029 if goals are met.
She also received and immediately vested 581 performance-related shares tied to 2023–2025 awards. To cover tax liabilities on a total of 4,232 vested shares, 1,985 shares were withheld and sold through a company cashless program at prices ranging from $49.38 to $50.15, leaving her with 16,186 directly held common shares plus previously granted restricted and performance awards.
Bankwell Financial Group, Inc. principal accounting officer Angelo G. Fusaro reported stock compensation and a related tax sale. On February 9, 2026, he received 414 shares of common stock at $0 under the 2022 Stock Plan, vesting in three equal annual installments starting on February 7, 2027.
On the same date, 316 shares were sold at $49.88 through a company cashless program to cover taxes on the vesting of 852 shares. Following these transactions, he directly owned 2,273 common shares, and the filing outlines several prior restricted stock grants under the 2022 plan with staggered vesting through future years.
Bankwell Financial Group Inc. is the issuer for a planned Rule 144 sale of common stock. A holder filed to sell 1,062 shares of common stock with an aggregate market value of $52,874.00 through Citigroup Global Markets on NASDAQ, with an approximate sale date of 02/09/2026.
The 1,062 shares were acquired on 02/09/2026 via restricted stock vesting from Bankwell Financial Group Inc. as compensation. The filing notes that the person signing does not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Bankwell Financial Group Inc. has a planned stock sale disclosed under Rule 144. A shareholder filed to sell 3,794 shares of common stock through Citigroup Global Markets on or about 02/09/2026, with an aggregate market value of $189,071.00 on the NASDAQ.
The 3,794 shares were acquired on 02/09/2026 via restricted stock vesting from Bankwell Financial Group Inc. as compensation. The filing notes that 7,877,443 shares of common stock were outstanding, providing context for the size of the proposed sale.
Bankwell Financial Group, Inc. received a notice that a shareholder plans to sell 1,985 shares of its common stock under Rule 144. The shares, valued at an aggregate market price of $98,852.00, are to be sold through Citigroup Global Markets on NASDAQ around February 9, 2026.
The shares come from restricted stock that vested on February 9, 2026, as compensation from Bankwell Financial Group, Inc. The filing also notes that Christine Chivily sold 2,533 common shares on November 12, 2025, generating gross proceeds of $116,164.21.
Bankwell Financial Group, Inc. is reporting a planned insider sale of common stock under Rule 144. The notice covers 1,876 common shares to be sold through Citigroup Global Markets, listed on the NASDAQ exchange, with an aggregate market value of $93,520 and 7,877,443 shares outstanding.
The shares to be sold were acquired on February 9, 2026 via restricted stock vesting from Bankwell Financial Group, Inc. as compensation, with the same date shown as the payment date. The seller represents they are not aware of undisclosed material adverse information about the company.
Bankwell Financial Group, Inc. has a planned sale of 5,056 shares of common stock under Rule 144. The shares are to be sold through Citigroup Global Markets, Inc. on the NASDAQ, with an aggregate market value of $251,746.00 and 7,877,443 shares outstanding.
The seller acquired the 5,056 common shares on 02/09/2026 through restricted stock vesting from Bankwell Financial Group, Inc. as compensation, with payment also dated 02/09/2026. The approximate date of sale listed is 02/09/2026, and no other sales in the past three months are disclosed.
Bankwell Financial Group, Inc. reported that it issued a press release outlining its operating results for the period ended December 31, 2025, and furnished a slide presentation reviewing financial results and trends through that same period as exhibits to this report.
The company also announced that its Board of Directors approved a quarterly cash dividend of $0.20 per share, payable on February 20, 2026 to shareholders of record as of February 10, 2026. The press release and investor presentation are furnished, not filed, limiting their use for certain legal purposes.
BlackRock, Inc. has filed a Schedule 13G reporting a passive ownership stake in Bankwell Financial Group, Inc. (BWFG) common stock. BlackRock reports beneficial ownership of 409,432 shares, representing 5.2% of Bankwell’s outstanding common stock as of 12/31/2025. It has sole voting power over 401,905 shares and sole dispositive power over the full 409,432 shares, with no shared voting or dispositive power.
The filing states that these securities are held in the ordinary course of business and are not held for the purpose of changing or influencing control of Bankwell. Various underlying clients and accounts have rights to dividends or sale proceeds, but no single underlying interest exceeds five percent of Bankwell’s total outstanding common shares.
Bankwell Financial Group, Inc. director Jeffrey R. Dunne reported buying 363 shares of common stock on December 5, 2025 at $47.64 per share through a deferred compensation plan, bringing his indirect holdings in that plan to 5,448 shares.
He also beneficially owns 3,033 shares of common stock directly, plus restricted stock granted under the 2022 Bankwell Financial Group, Inc. Stock Plan: 1,800 shares granted on February 7, 2025 that vest in three 600-share installments on February 7, 2026, February 7, 2027 and February 7, 2028, and 1,600 shares granted on December 29, 2023, with 533 shares vested on February 7, 2025 and additional 533- and 534-share tranches scheduled to vest on February 7, 2026 and February 7, 2027. As of the filing date, 533 of those 2023 grant shares have vested.